dc.contributor.author | Mangan, Mehmet Serhat | |
dc.contributor.author | Cinar, Esat | |
dc.contributor.author | Zengin, Mehmet Ozgur | |
dc.contributor.author | Karaca, Abdullah | |
dc.contributor.author | Dogan, Cezmi | |
dc.contributor.author | Tuncer, Ibrahim | |
dc.contributor.author | Bilgin, Sinan | |
dc.date.accessioned | 2021-03-02T18:09:46Z | |
dc.date.available | 2021-03-02T18:09:46Z | |
dc.identifier.citation | Tuncer I., Bilgin S., Zengin M. O. , Mangan M. S. , Karaca A., Dogan C., Cinar E., "Effect of brimonidine tartrate 0.15% on scotopic pupil size and upper eyelid position: controlled trial", EYE, 2020 | |
dc.identifier.issn | 0950-222X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_ed5faff3-5059-42b1-8430-ea26dad28d17 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/4624 | |
dc.identifier.uri | https://doi.org/10.1038/s41433-020-1007-9 | |
dc.description.abstract | Background To evaluate the effect of brimonidine tartrate 0.15% ophthalmic solution on pupil size under scotopic condition and upper eyelid position. Methods This study comprised 72 eyes of 36 healthy subjects. A single drop of brimonidine tartrate 0.15% ophthalmic solution was instilled in the right eye and artificial tear was instilled in the left eye. Pupil size was measured using an infra-red pupillometer under scotopic condition before and at 30 min, 2, 4, 6, 8 and 10 h after instillation. Measurement of margin reflex distance 1 (MRD1) was performed using a millimetre ruler before and after at 10 min after instillation. Results The mean age of the subjects was 32.19 +/- 11.43 years (range 10-52 years), 17 were female and 19 were male. Before brimonidine instillation, the mean pupil size was 6.09 +/- 1.03 mm in the brimonidine eyes and 6.06 +/- 1.04 mm in the control eyes. There was a significant decrease in mean pupil size at 30 min (4.45 +/- 1.04), 2 h (4.49 +/- 1.06), 4 h (4.59 +/- 1.06), 6 h (4.89 +/- 1.06) and 8 h (5.38 +/- 1.02) after instillation compared to before in brimonidine eyes (p < 0.001 for all). There was a significant miosis continued for at least 6 h (5.95 +/- 1.03) in control eyes (p < 0.001). There was no significant change in MRD1, before and after instillation both in brimonidine and control eyes. Conclusions Brimonidine tartrate 0.15% had a significant miosis under scotopic condition for at least 8 h after instillation and had a significant miosis on the untreated eye for at least 6 h. | |
dc.language.iso | eng | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Göz Hastalıkları ve Cerrahisi | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | OFTALMOLOJİ | |
dc.title | Effect of brimonidine tartrate 0.15% on scotopic pupil size and upper eyelid position: controlled trial | |
dc.type | Makale | |
dc.relation.journal | EYE | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.contributor.firstauthorID | 2282519 | |